🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the safety and tolerability, characterize the dose-limiting toxic...
Status
Completed
Location
H. Lee Moffitt Cancer Center & Research Institute
Start Date
2012-12
Trial ID
NCT01750580
Treatments Being Tested
To assess the safety and tolerability, characterize the dose limiting toxic...
Status
Completed
Location
University Of Arkansas For Medical Sciences
Start Date
2014-12-09
Trial ID
NCT02252263
Treatments Being Tested
To assess the safety and tolerability and preliminary anti-tumor activity o...
Status
Completed
Location
Ucsf
Start Date
2012-10-07
Trial ID
NCT01714739
Treatments Being Tested
Patients with muscle-invasive bladder cancer (MIBC) who can not receive cis...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2019-03-22
Trial ID
NCT03532451
Treatments Being Tested
The goal of this clinical research study is to learn if lirilumab and Opdiv...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2016-03-21
Trial ID
NCT02599649
Treatments Being Tested
This proof-of-concept platform trial is designed to cover the targeting of ...
Status
Recruiting
Location
Rigshospitalet
Start Date
2016-08-03
Trial ID
NCT02813135
This phase II trial studies the side effects lirilumab and azacitidine and ...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2015-04-20
Trial ID
NCT02399917
Treatments Being Tested
Double-Blind Placebo-Controlled Randomized Phase 2 Study evaluating the eff...
Status
Completed
Location
CHU d'Amiens
Start Date
2012-10
Trial ID
NCT01687387
Treatments Being Tested
The purpose of this study is to determine whether lirilumab in combination ...
Status
Completed
Location
Local Institution
Start Date
2017-07-14
Trial ID
NCT03203876
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, and eff...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2018-03-21
Trial ID
NCT03347123
Treatments Being Tested